Ticker Details
Xilio Therapeutics, Inc. Common Stock
IPO Date:	October 18, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$60.73M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.20 | 5.23%
Avg Daily Range (30 D):	$0.17 | 1.88%
Avg Daily Range (90 D):	$0.19 | 2.26%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.02M
Avg Daily Volume (90 D):	.03M

Trade Size
Avg Trade Size (Sh.):	359
Avg Trade Size (Sh.) (30 D):	78
Avg Trade Size (Sh.) (90 D):	106

Institutional Trades
Total Institutional Trades:	19
Avg Institutional Trade:	$2.18M
Avg Institutional Trade (30 D):	$4.6M
Avg Institutional Trade (90 D):	$4.6M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.69M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	42.67K

News

Apr 3, 2026 @ 8:30 PM Xilio Therapeutics Announces Inducement Grants Und... Source: Na

Feb 12, 2026 @ 2:34 AM Xilio Therapeutics Announces Pricing of Underwritt... Source: Not Specified

Oct 3, 2025 @ 1:00 PM Xilio Therapeutics Announces Upcoming Presentation... Source: Xilio Therapeutics

Jun 5, 2025 @ 10:38 PM Xilio Therapeutics Announces Closing of $50.0 Mill... Source: N/A

Jun 2, 2025 @ 10:11 AM Xilio Therapeutics Announces Proposed Public Offer... Source: Globe Newswire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-4.76	$-.33	$-.58
Diluted EPS	$-4.76	$-.33	$-.58
Revenue	$64.09M	$18.69M	$12.65M
Gross Profit
Net Income / Loss	$-21.83M	$-6.37M	$-9.53M
Operating Income / Loss	$-31.37M	$-3.49M	$-14.11M
Cost of Revenue
Net Cash Flow	$14.51M	$-14.29M	$12.81M
PE Ratio

Splits
Mar 16, 2026	1:14